Immediate Impact
2 standout
Citing Papers
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
2024 Standout
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
2023 Standout
Works of Laura Burns being referenced
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Laura Burns | 13 | 1 | 1 | 3 | 3 | 3 | 13 | |
| F Aquila | 10 | 1 | 2 | 2 | 3 | 13 | ||
| Jefri J Paul | 12 | 3 | 3 | 5 | 2 | 18 | ||
| Gloria Crowl | 9 | 1 | 1 | 4 | 2 | 9 | ||
| Christina Fichter | 9 | 1 | 2 | 2 | 16 | |||
| Jonathan Stoever | 13 | 3 | 3 | 14 | ||||
| Arttu Reinholm | 10 | 1 | 2 | 2 | 11 | |||
| Andrew Klevos | 10 | 1 | 3 | 3 | 15 | |||
| Katelin Katsis | 8 | 1 | 1 | 3 | 4 | 14 | ||
| Sandrine Fernandes Pellerin | 8 | 1 | 2 | 2 | 9 | |||
| Anette Kolderup | 12 | 3 | 1 | 2 | 2 | 15 |
All Works
Loading papers...